THE INTRAVENOUS USE OF A COMBINATION OF SODIUM PARA-AMINOSALICYLATE AND POLYVINYL PYRROLIDONE IN THE CHEMOTHERAPY OF TUBERCULOSIS

No abstract is available for this paper.

• Publication year

  1953

• Venue

  American Journal of the Medical Sciences

• Publication date

  1953-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/00000441-195305000-00014PMID 13040342
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• THE FATE OF INTRAVENOUSLY ADMINISTERED POLYVINYLPYRROLIDONE

  1952cited by this paper
• FATE AND DISPOSAL OF PLASMA SUBSTITUTES

  1952cited by this paper
• [Method and complications of intravenous PAS-infusions].

  1951cited by this paper
• [Intravenous application of paraaminosalicylic acid].

  1951cited by this paper
• The subcutaneous administration of the sodium salt of para-aminosalicylic acid in the treatment of tuberculosis.

  1951cited by this paper
• The intravenous administration of p-aminosalicylic acid.

  1949cited by this paper

• Pharmacotherapeutic combinations of p-aminosalicylic acid.

  1977cites this paper
• Tuberculostatic activity and depot properties of polymeric derivatives of para-aminosalicylic acid with different structures

  1976cites this paper
• The synthetic antimicrobial agents; applied pharmacology.

  1956cites this paper
• POLYVINYLPYRROLIDONE AS A DRUG RETARDANT: Part III. Effect on Sodium p‐Aminosalicylate

  1954cites this paper
• The clinical use of intravenous sodium para-aminosalicylate and polyvinyl pyrrolidone.

  1954cites this paper